The World Anti-Doping Agency (WADA) prohibits AOD-9604 as a non-approved substance and potential performance-enhancing agent in athletics, citing concerns about unfair advantage through lean body mass gains (if efficacious, which remains unproven)
GLP-1 (7-37) was obtained from Tocris Bioscience (Minneapolis, MN), while semaglutide and exendin-4 were obtained from MedChemExpress LLC (Monmouth Junction, NJ)
Tirzepatide is a dual agonist that targets glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)
Launched under the brand name Obeda, it was being seen by the company as a move that was supportive of all attempts at democratizing advanced metabolic therapy from India to the world, as Deepak Sapra, CEO API and Services, Dr Reddys summed it all up
The move represents the most significant regulatory shift in the peptide space in years
It also serves to regulate activities of vital organs and blood vessels and communication between nerves and muscles
![Tirzepatide vs. Semaglutide: Which GLP-1 Better Preserves Muscle? [SURMOUNT-5 Data]](https://www.clinicalnutritioncenter.com/wp-content/uploads/2026/04/research-image-2026-04-10-1024x559.jpg)
